Trump MFN drug pricing policy seen reshaping pharma investment flows
President Donald Trump’s “most-favoured nation” drug pricing policy may boost affordability, with the biggest impact potentially shifting global pharma investment flows.
WINNERS AND LOSERS FROM TRUMP'S DRUG PRICING POLICYPresident Donald Trump's "most-favoured nation" (MFN) drug pricing policy may be grabbing the headlines for its promise to make healthcare more affordable for Americans, but its biggest impact could be on global pharma investment flows.The White Ho…